Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
421
-
422
-
423
LPS-induced decrease in Sp1 DNA binding activity is associated with an increased NF-κB binding activity.
Published 2015“…<p>Wild type (WT) mice were injected with saline (1 ml/kg, Con) or <i>Samonelia Enteritidis</i> LPS (10 mg/kg, i.p.). Lung tissue level of Sp1 (A) or NF-κB (B) DNA binding activity was measured at the indicated times (in minutes) after LPS injection, using electrophoretic mobility shift assay (EMSA). …”
-
424
-
425
-
426
-
427
-
428
-
429
-
430
Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy
Published 2013“…However, tacrolimus wasn't effective with a dose of 0.05 mg/kg/day in patients taking ARB. …”
-
431
-
432
-
433
-
434
APB5, but not APA5, decreases apoptosis in alveolar epithelial cells in lungs of BLM-treated mice.
Published 2018“…The administration of APA5 did not change the number of TUNEL-positive cells from that in BLM-treated mice, whereas that of APB5 significantly decreased them. …”
-
435
Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on pre-specified atherosclerotic traits.
Published 2020“…<p>Odds Ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on primary atherosclerotic traits for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
-
436
-
437
-
438
The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of sucrose using the drinking in the dark model in mice.
Published 2013“…<p>The highest dose of ezlopitant (15 mg/kg) decreased consumption of 5% sucrose (<b>A</b>). …”
-
439
-
440